These results are consistent with the postulate that melatonin inhibits LA uptake, 13-HODE formation and proliferative activity in tissue-isolated human breast cancer xenografts via suppression of AKT phosphorylation activity. This evidence concerns the gene AKT1 and breast carcinoma.